Sentence examples for replacement trial from inspiring English sources

Dr. Jacques E. Rossouw, who is acting director of the hormone replacement trial, said in an interview yesterday that even though it was too soon to say whether the increased risk of heart attacks and strokes would hold up as the study continued, he felt morally obliged to inform the women about the finding.

Finally, the keenly awaited French 'steroid replacement' trial in sepsis has been published [ 7].

Molecular replacement trial models were constructed based on the main chain of the BRCT repeat from 1JNX with side chains mutated to conform to the BARD1 sequence based on the structural alignment.

A study investigating the impact of a placebo group on women's willingness to participate in a hypothetical hormone replacement trial 59 suggests that the number likely to take part may be less when a non-active comparator is included (RR 0.76, 95% CI 0.59 to 0.99).

In the search of new cell sources for replacement trials, stem cells from embryonic and adult origins represent a key alternative.

Additionally, dietary modification and oral enzyme replacement trials using synthetic sucrase (sacrosidase) have been employed to determine if they can clinically alleviate symptoms of sucrase-isomaltase deficiency [22, 23].

Molecular replacement trials were performed using the program MOLREP and the model of the S. enterica Typhimurium PhoQ PD from the PDB databank (PDB 1YAX) (Cho et al., 2006; Vagin and Teplyakov, 2010).

While the results of randomised testosterone replacement trials in cancer survivors are eagerly awaited, the clock is ticking for GCT survivors who are at clear risk of developing significant morbidity related to long-term androgen deficiency.

This would seem to be partially attributable to the general lack of rehabilitation research undertaken on orthopaedic surgery patients post discharge, rather than hip replacement patients per se, since a recent search for knee replacement trials by the authors revealed a similar lack of trials [ 14].

Again, molecular replacement trials with PHASER (McCoy et al., 2007 ) with the open, unlatched and locked bowl structures showed that the open structure was most consistent with the data since no solutions could be found using either the unlatched or locked conformations of the bowl as search models.

These preclinical animal studies demonstrate the dose-dependent clearance of tissue and plasma GL-3 by administered α-Gal A, thereby providing the in vivo rationale and the critical pharmacokinetic and pharmacodynamic data for the design of enzyme-replacement trials in patients with Fabry disease.